Cargando…
A retrospective study of the safety and efficacy of rituximab in Iranian patients with myasthenia gravis: A single-center experience
Background: This retrospective cohort study was conducted to evaluate the efficacy and tolerance of rituximab (RTX) for the management of myasthenia gravis (MG). Methods: This retrospective cross-sectional study was conducted on 61 patients with refractory and non-refractory MG who received RTX. The...
Autores principales: | Ziaadini, Bentolhoda, Karimi, Narges, Panahi, Akram, Okhovat, Ali Asghar, Fatehi, Farzad, Nafissi, Shahriar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860210/ https://www.ncbi.nlm.nih.gov/pubmed/38011443 http://dx.doi.org/10.18502/cjn.v21i2.10492 |
Ejemplares similares
-
Myasthenia gravis associated with novel coronavirus 2019 infection: A report of three cases
por: Karimi, Narges, et al.
Publicado: (2021) -
Validation of myasthenia gravis activity of daily living questionnaire: Persian version
por: Faghani, Shahriar, et al.
Publicado: (2022) -
Guillain-Barre Syndrome and COVID-19 Vaccine: A Report of Nine Patients
por: Karimi, Narges, et al.
Publicado: (2021) -
Zytux in Refractory Myasthenia Gravis: A Multicenter, Open-Labeled, Clinical Trial Study of Effectiveness and Safety of a Rituximab Biosimilar
por: Fatehi, Farzad, et al.
Publicado: (2021) -
Cholinergic neuromuscular hyperactivity in a patient with anti-muscle-specific tyrosine kinase myasthenia gravis
por: Okhovat, Ali Asghar, et al.
Publicado: (2020)